Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: A double-blind, placebo-controlled study

Stefano Erzegovesi, Emanuela Guglielmo, Francesca Siliprandi, Laura Bellodi

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: A double-blind, placebo-controlled study'. Together they form a unique fingerprint.

Medicine & Life Sciences